ContinUse Biometrics is the only clinically-validated contact-free sensing device developed for both cardiac & respiratory assessment. The technology allows the simultaneous detection of multiple wellness indicators with medical-grade accuracy. The company holds 15 patent families and 25 registered patents.
Designing a mobile app that communicates with the sensor to improve the experience of patients and healthcare personnel, who want to measure the patients' vital signs using this contactless technology because they value the possibility of tracking their health continuously and seamlessly.
We created the company's complete interactive solution, from the B2C mobile and tablet apps to the doctor console and admin management system. The goal was to simplify the way the patients and their caregivers setup the sensor and complete the measuring sessions, and make it accessible to all age groups.
The console allows doctors to track their patients' vital signs on a daily basis while pointing out urgent clinical cases (Alerts). We included the possibility for the doctors to communicate internally, in addition to getting reports to support their current clinical research.
The platform allows admins and clinic services to create a clinic environment that supports the tracking sensors by adding multiple locations, departments, control the devices and sensors remotely, and create users including various permission types (e.g super Admins, technicians, health professional and patients.
"Very professional, deliver quickly, and in the highest standards."
"For over 3 years, Rikover helped us achieve our goal in creating the most ideal experience for our users, from the strategic part of defining the user needs, features, usage flows, detailed UX concepts into high-leveled UI visual designs, and supporting our development team. We consider Rikover as an integral part of our journey. Rikover's very professional, deliver quickly, and in the highest standards. I highly recommend Rikover and plan to continue our collaboration in the future."